Last reviewed · How we verify

NCT04256876: TaPaS

TTNS Versus Sham Therapy for Children With iOAB (TaPaS Part I)

Terminated NA Last updated 4 January 2023
What this trial tests

NA trial testing TTNS in Overactive Bladder Syndrome in 6 participants. Terminated before completion.

Timeline
7 November 2018
Primary endpoint
1 July 2020
1 July 2020

Quick facts

Lead sponsorUniversity Hospital, Ghent
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment6
Start date7 November 2018
Primary completion1 July 2020
Estimated completion1 July 2020
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Ghent

Who can join

Adults 5 to 12, any sex, with Overactive Bladder Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Part I of the TaPaS trial forms part of a twofold clinical RCT: Part 1) A prospective RCT comparing the efficacy of transcutaneous tibial nerve stimulation (TTNS) with TTNS sham therapy for children with idiopathic overactive bladder on clinical and patient reported outcomes (PROMS). Part 2) A prospective RCT comparing TTNS versus Percutaneous tibial nerve stimulation (PTNS) on clinical outcomes and PROMS.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Clinical efficacy of transcutaneous tibial nerve stimulation (TTNS) versus sham therapy (part I) and TTNS versus percutaneous tibial nerve stimulation (PTNS) (part II) on the short term in children with the idiopathic overactive bladder syndrome: protocol for part I of the twofol
    Ghijselings L, Renson C, Van de Walle J, Everaert K, et al · · 2021 · cited 5× · PMID 33810804 · DOI 10.1186/s13063-021-05117-8
  2. Clinical efficacy of Transcutaneous Tibial Nerve Stimulation (TTNS) versus Sham therapy (Part I) and TTNS versus Percutaneous Tibial Nerve Stimulation (PTNS) (Part II) on the short term in children with the idiopathic overactive bladder syndrome: Protocol for Part I of the two-fo
    Ghijselings L, Renson C, Walle JV, Everaert K, et al · · 2021 · DOI 10.21203/rs.3.rs-35470/v2

Verify or expand the search:

Other trials of TTNS

Trials testing the same drug.

Other recruiting trials for Overactive Bladder Syndrome

Currently open trials in the same condition.

Other University Hospital, Ghent trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04256876.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing